Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy Meeting Abstract
| Authors: | Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; Linette, G. P.; Milella, M.; Hennessy, M.; Bajars, M.; Hicking, C.; D'Angelo, S. P. |
| Abstract Title: | Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 491s |
| Language: | English |
| ACCESSION: | WOS:000442916003284 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9507 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9507 -- Source: Wos |
